Ju Hyun Kim

5PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersPharmaceutical delivery technologiesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2023
Clinical Significance of Combined Epithelial-Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma.

Seung Kak Shin, Sujin Ryu, Seungyoon Nam

|Mar 22, 2022
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.

Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon

|Oct 13, 2021
The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study.

Jeong-Ju Yoo, Jung Hyun Kwon, Young Seok Kim

|Oct 29, 2020
Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis.

Seung Kak Shin, Hyung Joon Yim, Jeong Han Kim

|Oct 26, 2019
Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study.

Seung Kak Shin, Jin Woo Lee, Hannah Ra

Pageof 1

Frequent Collaborators

4 joint publications

Seung Kak Shin

3 joint publications

Oh Sang Kwon

2 joint publications

Jin-Woo Lee

2 joint publications

Young Kul Jung